China’s top trade official urged Eli Lilly & Co. to bolster its investment in the country, vowing to create vast opportunities for international pharmaceutical companies even as the US works to cut those ties.

China wants Lilly to provide more high quality medical products and services to the world’s second largest pharmaceutical market, Commerce Minister Wang Wentao told Lilly Chief Executive Officer David Ricks at a meeting on Thursday, according to a statement from the ministry.